-
in discovering potential therapeutic candidates to target mitochondria vulnerability, including a nucleoside analog, small GTPase inhibitor, natural plant extract, monoclonal and bispecific antibodies
-
-Oncology are looking for several highly motivated and creative Postdoctoral Fellows. The group conducts the most forefront science and is highly productive with publications in high-impact journals such as
-
-Oncology are looking for several highly motivated and creative Postdoctoral Fellows. The group conducts the most forefront science and is highly productive with publications in high-impact journals such as
-
the most forefront science and is highly productive with publications in high-impact journals in the past five years, Nature Cancer (2024), Blood (2022, 2019, 2019), Blood Cancer Journal (2022), Cell Stem
-
in discovering potential therapeutic candidates to target mitochondria vulnerability, including a nucleoside analog, small GTPase inhibitor, natural plant extract, and monoclonal and bispecific
-
. The Li group conducts the most forefront science and is highly productive with publications in high-impact journals in the past five years, Nature Cancer (2023), Blood (2022, 2019, 2019), Blood Cancer
-
and Immuno-Oncology are looking for several highly motivated and creative Postdoctoral Fellows. The group conducts the most forefront science and is highly productive with publications in high-impact
-
conduct research in discovering potential therapeutic candidates to target mitochondria vulnerability, including a nucleoside analog, small GTPase inhibitor, natural plant extract, and monoclonal and
-
targeted therapies. 5) The role of extracellular vesicles/exosomes as in cancer pathogenesis and their role as disease biomarkers. Our group performs cutting-edge research in GI oncology, is very productive
-
, is very productive and publishes in high-impact journals such as Gastroenterology, JNCI, Clinical Cancer Research, Nature Communications, Annals of Surgery etc. Key Responsibilities include: Devise